Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 80 Head and Neck Neoplasms 72 Nasopharyngeal Carcinoma 61 Prostatic Neoplasms 51 Oropharyngeal Neoplasms 30 Carcinoma, Non-Small-Cell Lung 27 Rectal Neoplasms 23 Carcinoma, Squamous Cell 23 Breast Neoplasms 23 Glioblastoma 22 Uterine Cervical Neoplasms 18 Carcinoma 18 Neoplasm Metastasis 16 Brain Neoplasms 16 Nasopharyngeal Neoplasms 15 Pancreatic Neoplasms 14 Lung Neoplasms 13 Gliosarcoma 13 Glioma 13 Esophageal Neoplasms 13 Radiation Injuries 12 Mouth Neoplasms 12 Laryngeal Neoplasms 12 Esophageal Squamous Cell Carcinoma 12 Astrocytoma 12 Tongue Neoplasms 11 Hypopharyngeal Neoplasms 11 Sarcoma 10 Neoplasms 10 Salivary Gland Neoplasms 8

Interventions

Lenalidomide 4 Gemcitabine 4 Dexamethasone 4 Cyclophosphamide 4 Bortezomib 4 Nivolumab 3 Cisplatin 3 Carboplatin 3 vandetanib 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 2 pomalidomide 2 pembrolizumab 2 liposomal doxorubicin 2 fludarabine 2 durvalumab 2 capivasertib 2 Radiosurgery 2 Paclitaxel 2 Doxorubicin 2 Bevacizumab 2 Anthropogenic Effects 2 venetoclax 1 umbralisib 1 ublituximab 1 tremelimumab 1 tivozanib 1 ricolinostat 1 regorafenib 1 pazopanib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease Progression × Radiotherapy, Intensity-Modulated × Clear all

NCT06306170 2025-04-22

GYN-ART

IRCCS San Raffaele

Radiation Injuries, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡